extrafine triple inhaled therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for extrafine triple inhaled therapy, covering 2026-02-03 to 2026-02-03. Get the full timeline:
Most recent: Clinical Trial Update: Measuring Small-Airways Disease Improvement After Step-up to Extrafine TRIple or High-dose ICS/LABA in Patients Uncontrolled on Medium Dose ICS/LABA eXploring T2 Inflammation